Targeting a tumor trigger

Heidelberg, 15 March 2017 – Many cancer patients that receive chemotherapy go into remission at first, but relapse after treatment is discontinued. There is increasing evidence that this is due to the presence of cancer stem cells – cells that reproduce indefinitely and may seed new tumors. A research group from Milan, Italy, now devised a strategy to specifically target cancer stem cells in some cancers and reduce their tumor-generating potential. The results are published today in EMBO Molecular Medicine. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)